Exact controllability of a second order integro-differential equation with a pressure term

This paper is concerned with the boundary exact controllability of the equation $$u''-\Delta u-\int_0^t g(t-\sigma)\Delta u(\sigma) d\sigma=-\nabla p$$ where $Q$ is a finite cilinder $\Omega\times]0,T[$, $\Omega$ is a bounded domain of $R^n$, $u=(u_1(x,t),\ldots,u_n(x,t))$, $x=(x_1,\ldots,x_n)$ are $n$-dimensional vectors and $p$ denotes the pressure term. The result is obtained by applying HUM (Hilbert Uniqueness Method) due to J. L. Lions. The above equation is a simple model of dynamical elasticity equations for incompressible materials with memory

Nutrição De Tithonia Diversifolia E Atributos Do Solo Adubado Com Biofertilizante Em Sistema Irrigado

The fertilization with biofertilizer associated with the use of irrigation favors nutrient uptake by plants and soil chemical properties; however, these effects are little studied in Tithonia diversifolia in semiarid regions. This study evaluated the effect of doses of bovine biofertilizer and irrigation on accumulation of nutrients in the leaves of Tithonia diversifolia plants and on soil chemical attributes. The study was carried out from December 3, 2014 to November 28, 2015, and arranged in a 2 x 5 factorial scheme, consisting of five doses of bovine biofertilizer (0, 40, 80, 120 and 160 m3 ha-1), combined with and without irrigation. The experiment was set in a randomized block design, using three replicates. Irrigation promoted increased accumulation of N, P, K, Ca, Mg, S, Zn, Fe, Mn, Cu and B in leaves of Tithonia diversifolia in the first cutting. However, the high bicarbonate concentration in the irrigation water and the occurrence of rainfall during the second crop increased the accumulation of Cu in the leaves of Tithonia diversifolia under rainfed condition, compared with irrigated plants. The increase in biofertilizer doses contributed to the increment of base saturation and the contents of organic matter, P and K in soil. © 2016, Departamento de Engenharia Agricola - UFCG/Cnpq. All rights reserved.20111008101

Some thoughts on neural network modelling of micro-abrasion-corrosion processes

There is increasing interest in the interactions of microabrasion, involving small particles of less than 10 μm in size, with corrosion. This is because such interactions occur in many environments ranging from the offshore to health care sectors. In particular, micro-abrasion-corrosion can occur in oral processing, where the abrasive components of food interacting with the acidic environment, can lead to degradation of the surface dentine of teeth. Artificial neural networks (ANNs) are computing mechanisms based on the biological brain. They are very effective in various areas such as modelling, classification and pattern recognition. They have been successfully applied in almost all areas of engineering and many practical industrial applications. Hence, in this paper an attempt has been made to model the data obtained in microabrasion-corrosion experiments on polymer/steel couple and a ceramic/lasercarb coating couple using ANN. A multilayer perceptron (MLP) neural network is applied and the results obtained from modelling the tribocorrosion processes will be compared with those obtained from a relatively new class of neural networks namely resource allocation network

Role of SOX family of transcription factors in central nervous system tumors

SOX genes are developmental regulators with functions in the instruction of cell fate and maintenance of progenitor’s identity during embryogenesis. They play additional roles during tissue homeostasis and regeneration in adults particularly in the Central Nervous System (CNS). In the last years a growing number of evidences has shown that mutations and dysfunction of SOX factors are implicated in several human diseases, including a variety of cancers. In this review, we will summarize the current knowledge about SOX family in CNS tumors and their role in the origin and maintenance of the subpopulation of cancer stem cells in these tumors

Experiments with firefly algorithm

Firefly Algorithm (FA) is one of the recent swarm intelligence methods developed by Xin-She Yang in 2008 [12]. FA is a stochastic, nature-inspired, meta- heuristic algorithm that can be applied for solving the hardest optimization problems. The main goal of this paper is to analyze the influence of changing some parameters of the FA when solving bound constrained optimization problems. One of the most important aspects of this algorithm is how far is the distance between the points and the way they are drawn to the optimal solution. In this work, we aim to analyze other ways of calculating the distance between the points and also other functions to com- pute the attractiveness of fireflies. To show the performance of the proposed modified FAs a set of 30 benchmark global optimization test problems are used. Preliminary experiments reveal that the obtained results are competitive when comparing with the original FA version.Fundação para a Ciência e a Tecnologia (FCT

Epidemiological And Molecular Mechanisms Aspects Linking Obesity And Cancer [mecanismos Epidemiológicos E Moleculares Que Associam Obesidade E Câncer]

About 25% of cancer cases globally are due to excess weight and a sedentary lifestyle. These results are alarming, as the world knows a pandemy of obesity and, in consequence, insulin resistance. Obesity may increase risk for various cancers by several mechanisms, including increasing sex and metabolic hormones, and inflammation. Here, we present a review of epidemiological and molecular evidences linking obesity and cancer - particularly colorectal, post-menopausal breast, endometrial, pancreatic, high grade prostate, hepatocellular, gallbladder, kidney and esophageal adenocarcinoma. The expected striking increase in the incidence of cancer in the near future related to obesity turns the knowledge of this field of great impact as it is needed to the development of strategies to prevent and treat this disease.532213226Filozof, C., Gonzalez, C., Sereday, M., Mazza, C., Braguinsky, J., Obesity prevalence and trends in Latin-American countries (2001) Obes Rev, 2 (2), pp. 99-106Carvalheira, J.B., Saad, M.J., (2006) Arq Bras Endocrinol Metabol, 50 (2), pp. 360-367. , Insulin resistance/hyperinsulinemia associated diseases not included in the metabolic syndrome, Epub 2006 May 23, Review, Portugueseden, C.L., Carroll, M.D., Curtin, L.R., McDowell, M.A., Tabak, C.J., Flegal, K.M., Prevalence of overweight and obesity in the United States, 1999-2004 (2006) JAMA, 295 (13), pp. 1549-1555(2002) Weight Control and Physical Activity, , IARC - International Agency for Research on Cancer Working Group on the Evaluation of Cancer-Preventive Strategies, Lyon, France: IARC Press(2007) Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective, , WCRF - World Cancer Reserach Fund, Washington: American Institute for Cancer ResearchReeves, G.K., Pirie, K., Beral, V., Green, J., Spencer, E., Bull, D., Cancer incidence and mortality in relation to body mass index in the Million Women Study: Cohort study (2007) BMJ, 335 (7634), p. 1134. , Epub 2007 Nov 6Renehan, A.G., Tyson, M., Egger, M., Heller, R.F., Zwahlen, M., Body mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies (2008) Lancet, 371 (9612), pp. 569-578. , ReviewRenehan, A.G., Roberts, D.L., Dive, C., Obesity and cancer: Pathophysiological and biological mechanisms (2008) Arch Physiol Biochem, 114 (1), pp. 71-83. , ReviewCalle, E.E., Rodriguez, C., Walker-Thurmond, K., Thun, M.J., Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults (2003) N Engl J Med, 348 (17), pp. 1625-1638Yakar, S., Nunez, N.P., Pennisi, P., Brodt, P., Sun, H., Fallavollita, L., Increased tumor growth in mice with diet-induced obesity: Impact of ovarian hormones (2006) Endocrinology, 147 (12), pp. 5826-5834. , Epub 2006 Sep 7Dirx, M.J., Zeegers, M.P., Dagnelie, P.C., van den Bogaard, T., van den Brandt, P.A., Energy restriction and the risk of spontaneous mammary tumors in mice: A meta-analysis (2003) Int J Cancer, 106 (5), pp. 766-770Chow, W.H., Gridley, G., Fraumeni Jr., J.F., Järvholm, B., Obesity, hypertension, and the risk of kidney cancer in men (2000) N Engl J Med, 343 (18), pp. 1305-1311Larsson, S.C., Orsini, N., Wolk, A., Body mass index and pancreatic cancer risk: A meta-analysis of prospective studies (2007) Int J Cancer, 120 (9), pp. 1993-1998Pischon, T., Lahmann, P.H., Boeing, H., Friedenreich, C., Norat, T., Tjønneland, A., Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC) (2006) J Natl Cancer Inst, 98 (13), pp. 920-931Jenab, M., Riboli, E., Cleveland, R.J., Norat, T., Rinaldi, S., Nieters, A., Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition (2007) Int J Cancer, 121 (2), pp. 368-376Sandhu, M.S., Dunger, D.B., Giovannucci, E.L., Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer (2002) J Natl Cancer Inst, 94 (136), pp. 972-980Renehan, A.G., Zwahlen, M., Minder, C., O'Dwyer, S.T., Shalet, S.M., Egger, M., Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: Systematic review and meta-regression analysis (2004) Lancet, 363 (9418), pp. 1346-1353Ma, J., Pollak, M.N., Giovannucci, E., Chan, J.M., Tao, Y., Hennekens, C.H., Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3 (1999) J Natl Cancer Inst, 91 (7), pp. 620-625Wolpin, B.M., Meyerhardt, J.A., Chan, A.T., Ng, K., Chan, J.A., Wu, K., Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer (2009) J Clin Oncol, 27 (2), pp. 176-185. , Epub 2008 Dec 8Aaronson, S.A., Growth factors and cancer (1991) Science, 254 (5035), pp. 1146-1153. , ReviewKaaks, R., Lukanova, A., Energy balance and cancer: The role of insulin and insulin-like growth factor-I (2001) Proc Nutr Soc, 60 (1), pp. 91-106. , ReviewStattin, P., Lukanova, A., Biessy, C., Söderberg, S., Palmqvist, R., Kaaks, R., Obesity and colon cancer: Does leptin provide a link? (2004) Int J Cancer, 109 (1), pp. 149-152Carvalheira, J.B., Siloto, R.M., Ignacchitti, I., Brenelli, S.L., Carvalho, C.R., Leite, A., Insulin modulates leptin-induced STAT3 activation in rat hypothalamus (2001) FEBS Lett, 500 (3), pp. 119-124Björntorp, P., Obesity (1997) Lancet, 350 (9075), pp. 423-426Giovannucci, E., Colditz, G.A., Stampfer, M.J., Willett, W.C., Physical activity, obesity, and risk of colorectal adenoma in women (United States) (1996) Cancer Causes Control, 7 (2), pp. 253-263Stattin, P., Palmqvist, R., Söderberg, S., Biessy, C., Ardnor, B., Hallmans, G., Plasma leptin and colorectal cancer risk: A prospective study in Northern Sweden (2003) Oncol Rep, 10 (6), pp. 2015-2021Wei, E.K., Giovannucci, E., Fuchs, C.S., Willett, W.C., Mantzoros, C.S., Low plasma adiponectin levels and risk of colorectal cancer in men: A prospective study (2005) J Natl Cancer Inst, 97 (22), pp. 1688-1694Lukanova, A., Söderberg, S., Kaaks, R., Jellum, E., Stattin, P., Serum adiponectin is not associated with risk of colorectal cancer (2006) Cancer Epidemiol Biomarkers Prev, 15, pp. 401-402Huang, Z., Hankinson, S.E., Colditz, G.A., Stampfer, M.J., Hunter, D.J., Manson, J.E., Dual effects of weight and weight gain on breast cancer risk (1997) JAMA, 278 (17), pp. 1407-1411Travis, R.C., Key, T.J., Oestrogen exposure and breast cancer risk (2003) Breast Cancer Res, 5 (5), pp. 239-247Schairer, C., Hill, D., Sturgeon, S.R., Fears, T., Pollak, M., Mies, C., Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal women (2004) Int J Cancer, 108 (5), pp. 773-779Toniolo, P., Bruning, P.F., Akhmedkhanov, A., Bonfrer, J.M., Koenig, K.L., Lukanova, A., Serum insulin-like growth factor-I and breast cancer (2000) Int J Cancer, 88 (5), pp. 828-832Yang, G., Lu, G., Jin, F., Dai, Q., Best, R., Shu, X.O., Population-based, case-control study of blood C-peptide level and breast cancer risk (2001) Cancer Epidemiol Biomarkers Prev, 10 (11), pp. 1207-1211Hirose, K., Toyama, T., Iwata, H., Takezaki, T., Hamajima, N., Tajima, K., Insulin, insulin-like growth factor-I and breast cancer risk in Japanese women (2003) Asian Pac J Cancer Prev, 4 (3), pp. 239-246Hankinson, S.E., Willett, W.C., Colditz, G.A., Hunter, D.J., Michaud, D.S., Deroo, B., Circulating concentrations of insulin-like growth factor-I and risk of breast cancer (1998) Lancet, 351 (9113), pp. 1393-1396Goodwin, P.J., Ennis, M., Pritchard, K.I., Trudeau, M.E., Koo, J., Hartwick, W., Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes (2002) Breast Cancer Res Treat, 74 (1), pp. 65-76Vona-Davis, L., Rose, D.P., Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression (2007) Endocr Relat Cancer, 14 (2), pp. 189-206Miyoshi, Y., Funahashi, T., Kihara, S., Taguchi, T., Tamaki, Y., Matsuzawa, Y., Association of serum adiponectin levels with breast cancer risk (2003) Clin Cancer Res, 9 (15), pp. 5699-5704Mantzoros, C., Petridou, E., Dessypris, N., Chavelas, C., Dalamaga, M., Alexe, D.M., Adiponectin and breast cancer risk (2004) J Clin Endocrinol Metab, 89 (3), pp. 1102-1107Kaaks, R., Lukanova, A., Kurzer, M.S., Obesity, endogenous hormones, and endometrial cancer risk: A synthetic review (2002) Cancer Epidemiol Biomarkers Prev, 11 (12), pp. 1531-1543. , ReviewLukanova, A., Lundin, E., Micheli, A., Arslan, A., Ferrari, P., Rinaldi, S., Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women (2004) Int J Cancer, 108 (3), pp. 425-432Lukanova, A., Zeleniuch-Jacquotte, A., Lundin, E., Micheli, A., Arslan, A.A., Rinaldi, S., Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer (2004) Int J Cancer, 108 (2), pp. 262-268Nicodemus, K.K., Sweeney, C., Folsom, A.R., Evaluation of dietary, medical and lifestyle risk factors for incident kidney cancer in postmenopausal women (2004) Int J Cancer, 108 (1), pp. 115-121Bergstrom, A., Hsieh, C.C., Lindblad, P., Lu, C.M., Cook, N.R., Wolk, A., Obesity and renal cell cancer-a quantitative review (2001) Br J Cancer, 85 (7), pp. 984-990Pischon, T., Lahmann, P.H., Boeing, H., Tjonneland, A., Halkjaer, J., Overvad, K., Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) (2006) Int J Cancer, 118 (3), pp. 728-738Lindblad, P., Chow, W.H., Chan, J., Bergström, A., Wolk, A., Gridley, G., The role of diabetes mellitus in the aetiology of renal cell cancer (1999) Diabetologia, 42 (1), pp. 107-112Spyridopoulos, T.N., Petridou, E.T., Skalkidou, A., Dessypris, N., Chrousos, G.P., Mantzoros, C.S., Low adiponectin levels are associated with renal cell carcinoma: A case-control study (2007) Int J Cancer, 120 (7), pp. 1573-1578Pera, M., Manterola, C., Vidal, O., Grande, L., Epidemiology of esophageal adenocarcinoma (2005) J Surg Oncol, 92 (3), pp. 151-159Kubo, A., Corley, D.A., Body mass index and adenocarcinomas of the esophagus or gastric cardia: A systematic review and metaanalysis (2006) Cancer Epidemiol Biomarkers Prev, 15 (5), pp. 872-878Abnet, C.C., Freedman, N.D., Hollenbeck, A.R., Fraumeni Jr., J.F., Leitzmann, M., Schatzkin, A., A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma (2008) Eur J Cancer, 44 (3), pp. 465-471Corley, D.A., Kubo, A., Zhao, W., Abdominal obesity and the risk of esophageal and gastric cardia carcinomas (2008) Cancer Epidemiol Biomarkers Prev, 17 (2), pp. 352-358Hampel, H., Abraham, N.S., El-Serag, H.B., Meta-analysis: Obesity and the risk for gastroesophageal reflux disease and its complications (2005) Ann Intern Med, 143 (3), pp. 199-211Giovannucci, E., Michaud, D., The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas (2007) Gastroenterology, 132 (6), pp. 2208-2225Samanic, C., Gridley, G., Chow, W.H., Lubin, J., Hoover, R.N., Fraumeni Jr., J.F., Obesity and cancer risk among white and black United States veterans (2004) Cancer Causes Control, 15 (1), pp. 35-43Luo, J., Margolis, K.L., Adami, H.O., laCroix, A., Ye, W., Obesity and risk of pancreatic cancer among postmenopausal women: The Women's Health Initiative (United States) (2008) Br J Cancer, 99 (3), pp. 527-531. , Epub 2008 Jul 15Gapstur, S.M., Gann, P.H., Lowe, W., Liu, K., Colangelo, L., Dyer, A., Abnormal glucose metabolism and pancreatic cancer mortality (2000) JAMA, 283 (19), pp. 2552-2558Wolpin, B.M., Michaud, D.S., Giovannucci, E.L., Schernhammer, E.S., Stampfer, M.J., Manson, J.E., Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohort (2007) Br J Cancer, 97 (1), pp. 98-104. , Epub 2007 May 29MacInnis, R.J., English, D.R., Body size and composition and prostate cancer risk: Systematic review and meta-regression analysis (2006) Cancer Causes Control, 17 (8), pp. 989-1003Potischman, N., Swanson, C.A., Siiteri, P., Hoover, R.N., Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status (1996) J Natl Cancer Inst, 88 (11), pp. 756-758Chan, J.M., Stampfer, M.J., Giovannucci, E., Gann, P.H., Ma, J., Wilkinson, P., Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study (1998) Science, 279 (5350), pp. 563-566Larsson, S.C., Wolk, A., Obesity and the risk of gallbladder cancer: A meta-analysis (2007) Br J Cancer, 96 (9), pp. 1457-1461Caldwell, S.H., Crespo, D.M., Kang, H.S., Al-Osaimi, A.M., Obesity and hepatocellular carcinoma (2004) Gastroenterology, 127 (5 SUPPL. 1), pp. S97-S103. , ReviewPan, S.Y., Johnson, K.C., Ugnat, A.M., Wen, S.W., Mao, Y., Association of obesity and cancer risk in Canada (2004) Am J Epidemiol, 159 (3), pp. 259-268Lahmann, P.H., Hoffmann, K., Allen, N., van Gils, C.H., Khaw, K.T., Tehard, B., Body size and breast cancer risk: Findings from the European Prospective Investigation into Cancer and Nutrition (EPIC) (2004) Int J Cancer, 111 (5), pp. 762-771Olsen, C.M., Green, A.C., Whiteman, D.C., Sadeghi, S., Obesity and the risk of epithelial ovarian cancer: A systematic review and meta-analysis (2007) Eur J Cancer, 43 (4), pp. 690-709. , Epub 2007 Jan 12Olsen, C.M., Nagle, C.M., Whiteman, D.C., Purdie, D.M., Green, A.C., Webb, P.M., Body size and risk of epithelial ovarian and related cancers: A population-based case-control study (2008) Int J Cancer, 123 (2), pp. 450-456Engeland, A., Tretli, S., Hansen, S., Bjørge, T., Height and body mass index and risk of lymphohematopoietic malignancies in two million Norwegian men and women (2007) Am J Epidemiol, 165 (1), pp. 44-52. , Epub 2006 Oct 13Larsson, S.C., Wolk, A., Body mass index and risk of multiple myeloma: A meta-analysis (2007) Int J Cancer, 121 (11), pp. 2512-2516Druker, B.J., Imatinib as a paradigm of targeted therapies (2004) Adv Cancer Res, 91, pp. 1-30McKeown-Eyssen, G., Epidemiology of colorectal cancer revisited: Are serum triglycerides and/or plasma glucose associated with risk? (1994) Cancer Epidemiol Biomarkers Prev, 3 (8), pp. 687-695Giovannucci, E., Insulin and colon cancer (1995) Cancer Causes Control, 6 (2), pp. 164-179. , ReviewGiovannucci, E., Nutrition, insulin, insulin-like growth factors and cancer (2003) Horm Metab Res, 35 (11-12), pp. 694-704Calle, E.E., Kaaks, R., Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms (2004) Nat Rev Cancer, 4 (8), pp. 579-591Allen, N.E., Appleby, P.N., Kaaks, R., Rinaldi, S., Davey, G.K., Key, T.J., Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women (2003) Cancer Causes Control, 14 (1), pp. 65-74Holmes, M.D., Pollak, M.N., Hankinson, S.E., Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations (2002) Cancer Epidemiol Biomarkers Prev, 11 (9), pp. 862-867Myal, Y., Shiu, R.P., Bhaumick, B., Bala, M., Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture (1984) Cancer Res, 44 (12 PART. 1), pp. 5486-5490Wu, Y., Cui, K., Miyoshi, K., Hennighausen, L., Green, J.E., Setser, J., Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors (2003) Cancer Res, 63 (15), pp. 4384-4388Pollak, M., Blouin, M.J., Zhang, J.C., Kopchick, J.J., Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist (2001) Br J Cancer, 85 (3), pp. 428-430Creighton, C.J., Casa, A., Lazard, Z., Huang, S., Tsimelzon, A., Hilsenbeck, S.G., Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis (2008) J Clin Oncol, 26, pp. 4078-4085Carvalheira, J.B., Zecchin, H.G., Saad, M.J., (2002) Arq Bras Endocrinol Metabol, 46 (4), pp. 419-425. , Vias de sinalização da insulinaMoore, T., Beltran, L., Carbajal, S., Strom, S., Traag, J., Hursting, S.D., Dietary energy balance modulates signaling through the akt/mammalian target of rapamycin pathways in multiple epithelial tissues (2008) Cancer Prev Res, 1 (1), pp. 65-76. , Epub 2008 Mar 31Cantley, L.C., The phosphoinositide 3-kinase pathway (2002) Science, 296 (5573), pp. 1655-1657Inoki, K., li, Y., Zhu, T., Wu, J., Guan, K.L., TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling (2002) Nat Cell Biol, 4 (9), pp. 648-657Garami, A., Zwartkruis, F.J., Nobukuni, T., Joaquin, M., Roccio, M., Stocker, H., Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2 (2003) Mol Cell, 11 (6), pp. 1457-1466Hay, N., Sonenberg, N., Upstream and downstream of mTOR (2004) Genes Dev, 18 (16), pp. 1926-1945McManus, E.J., Alessi, D.R., TSC1-TSC2: A complex tale of PKB-mediated S6K regulation (2002) Nat Cell Biol, 4 (9), pp. E214-E216Roux, P.P., Ballif, B.A., Anjum, R., Gygi, S.P., Blenis, J., Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase (2004) Proc Natl Acad Sci U S A, 101 (37), pp. 13489-13494. , Epub 2004 Sep 1Inoki, K., Zhu, T., Guan, K.L., TSC2 mediates cellular energy response to control cell growth and survival (2003) Cell, 115 (5), pp. 577-590Harrington, L.S., Findlay, G.M., Lamb, R.F., Restraining PI3K: MTOR signalling goes back to the membrane (2005) Trends Biochem Sci, 30 (1), pp. 35-42Fantl, W.J., Muslin, A.J., Kikuchi, A., Martin, J.A., MacNicol, A.M., Gross, R.W., Activation of Raf-1 by 14-3-3 proteins (1994) Nature, 371 (6498), pp. 612-614Blagosklonny, M.V., Hsp-90-associated oncoproteins: Multiple targets of geldanamycin and its analogs (2002) Leukemia, 16 (4), pp. 455-462Kyriakis, J.M., App, H., Zhang, X.F., Banerjee, P., Brautigan, D.L., Rapp, U.R., Raf-1 activated MAP kinase kinase (1992) Nature, 358 (6385), pp. 417-421Yoon, S., Seger, R., The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions (2006) Growth Factors, 24 (1), pp. 21-44Murphy, L.O., Blenis, J., MAPK signal specificity: The right place at the right time (2006) Trends Biochem Sci, 31 (5), pp. 268-275. , Epub 2006 Apr 17Key, T.J., Appleby, P.N., Reeves, G.K., Roddam, A., Dorgan, J.F., Longcope, C., Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women (2003) J Natl Cancer Inst, 95 (16), pp. 1218-1226Pugeat, M., Crave, J.C., Elmidani, M., Nicolas, M.H., Garoscio-Cholet, M., Lejeune, H., Pathophysiology of sex hormone binding globulin (SHBG): Relation to insulin (1991) J Steroid Biochem Mol Biol, 40 (4-6), pp. 841-849McTiernan, A., Rajan, K.B., Tworoger, S.S., Irwin, M., Bernstein, L., Baumgartner, R., Adiposity and sex hormones in postmenopausal breast cancer survivors (2003) J Clin Oncol, 21 (10), pp. 1961-1966Fortunati, N., Fissore, F., Fazzari, A., Piovano, F., Catalano, M.G., Becchis, M., Estradiol induction of cAMP in breast cancer cells is mediated by foetal calf serum (FCS) and sex hormone-binding globulin (SHBG) (1999) J Steroid Biochem Mol Biol, 70 (1-3), pp. 73-80Fortunati, N., Fissore, F., Fazzari, A., Becchis, M., Comba, A., Catalano, M.G., Sex steroid binding protein exerts a negative control on estradiol action in MCF-7 cells (human breast cancer) through cyclic adenosine 3′,5′-monophosphate and protein kinase A (1996) Endocrinology, 137 (2), pp. 686-692Catalano, M.G., Frairia, R., Boccuzzi, G., Fortunati, N., Sex hormone-binding globulin antagonizes the anti-apoptotic effect of estradiol in breast cancer cells (2005) Mol Cell Endocrinol, 230 (1-2), pp. 31-37Lee, A.V., Jackson, J.G., Gooch, J.L., Hilsenbeck, S.G., Coronado-Heinsohn, E., Osborne, C.K., Enhancement of insulin-like growth factor signaling in human breast cancer: Estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo (1999) Mol Endocrinol, 13 (5), pp. 787-796Dunaif, A., Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis (1997) Endocr Rev, 18 (6), pp. 774-800Ehrmann, D.A., Barnes, R.B., Rosenfield, R.L., Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion (1995) Endocr Rev, 16 (3), pp. 322-353. , ReviewDruckmann, R., Rohr, U.D., IGF-1 in gynaecology and obstetrics: Update 2002 (2002) Maturitas, 41 (SUPPL. 1), pp. S65-S83Colangelo, L.A., Gapstur, S.M., Gann, P.H., Dyer, A.R., Liu, K., Colorectal cancer mortality and factors related to the insulin resistance syndrome (2002) Cancer Epidemiol Biomarkers Prev, 11 (4), pp. 385-391Schiff, R., Massarweh, S.A., Shou, J., Bharwani, L., Mohsin, S.K., Osborne, C.K., Cross-talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance (2004) Clin Cancer Res, 10 (1 PART. 2), pp. S331-S336Balkwill, F., Mantovani, A., Inflammation and cancer: Back to Virchow? (2001) Lancet, 357 (9255), pp. 539-545Roder, D.M., The epidemiology of gastric cancer (2002) Gastric Cancer, 5 (SUPPL. 1), pp. 5-11Ekbom, A., Risk of cancer in ulcerative colitis (1998) J Gastrointest Surg, 2 (4), pp. 312-313. , ReviewDhala, A., Pinsker, K., Prezant, D.J., Respiratory health consequences of environmental tobacco smoke (2004) Med Clin North Am, 88 (6), pp. 1535-1552+xiHotamisligil, G.S., Shargill, N.S., Spiegelman, B.M., Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance (1993) Science, 259 (5091), pp. 87-91Tsukumo, D.M., Carvalho-Filho, M.A., Carvalheira, J.B., Prada, P.O., Hirabara, S.M., Schenka, A.A., Loss-of-f

Transport properties of copper phthalocyanine based organic electronic devices

Ambipolar charge carrier transport in Copper phthalocyanine (CuPc) is studied experimentally in field-effect transistors and metal-insulator-semiconductor diodes at various temperatures. The electronic structure and the transport properties of CuPc attached to leads are calculated using density functional theory and scattering theory at the non-equilibrium Green's function level. We discuss, in particular, the electronic structure of CuPc molecules attached to gold chains in different geometries to mimic the different experimental setups. The combined experimental and theoretical analysis explains the dependence of the mobilityand the transmission coefficient on the charge carrier type (electrons or holes) and on the contact geometry. We demonstrate the correspondence between our experimental results on thick films and our theoretical studies of single molecule contacts. Preliminary results for fluorinated CuPc are discussed.Comment: 18 pages, 16 figures; to be published in Eur. Phys. J. Special Topic

Epidemiologia molecular de um surto de bacteriemia por Enterobacter cloacae e Enterobacter agglomerans ocorrido na região de Campinas, São Paulo, Brasil

A total of 73 isolates (57 Enterobacter cloacae and 16 Enterobacter agglomerans), recovered during an outbreak of bacteremia in the Campinas area, São Paulo, Brazil, were studied. Of these isolates, 61 were from parenteral nutrition solutions, 9 from blood cultures, 2 from a sealed bottle of parenteral nutrition solution, and one was of unknown origin. Of the 57 E. cloacae isolates, 54 were biotype 26, two were biotype 66 and one was non-typable. Of 39 E. cloacae isolates submitted to ribotyping, 87.2% showed the same banding pattern after cleavage with EcoRI and BamHI. No important differences were observed in the antimicrobial susceptibility patterns among E. cloacae isolates exhibiting the same biotype, serotype and ribotype. All E. agglomerans isolates, irrespective of their origin, showed same patterns when cleaved with EcoRI and BamHI. The results of this investigation suggest an intrinsic contamination of parenteral nutrition solutions and incriminate these products as a vehicle of infection in this outbreak.Foram estudadas um total de 73 cepas (57 de E. cloacae e 16 E. agglomerans), isoladas durante um surto de bacteriemia ocorrido na região de Campinas, S. Paulo. Entre estas cepas, 61 foram isoladas de solução de nutrição parenteral, 9 de sangue, 2 de bolsa fechada de solução de nutrição parenteral e uma era de origem desconhecida. Entre as 57 cepas de E. cloacae, a maioria das cepas foram do biotipo 26/sorotipo O3 (39 cepas) e do biotipo 26/OR (13). Entre as 39 cepas de E. cloacae ribotipadas, 87,2% apresentaram o mesmo padrão de bandas com EcoRI e BamHI. Cepas de E. cloacae pertencentes ao mesmo biotipo, sorotipo e ribotipo não apresentaram diferenças significativas em relação ao padrão de sensibilidade aos agentes antimicrobianos. Todas as cepas de E. agglomerans, independente da origem, pertenciam ao mesmo ribotipo após a clivagem com EcoRI e BamHI. Os resultados obtidos sugerem uma contaminação intrínseca das soluções de nutrição parenteral, incriminando-as como o veículo de transmissão dos agentes etiológicos do surto

The Two-Nucleon Potential from Chiral Lagrangians

Chiral symmetry is consistently implemented in the two-nucleon problem at low-energy through the general effective chiral lagrangian. The potential is obtained up to a certain order in chiral perturbation theory both in momentum and coordinate space. Results of a fit to scattering phase shifts and bound state data are presented, where satisfactory agreement is found for laboratory energies up to about 100 Mev.Comment: Postscript file; figures available by reques

New syntheses of novel arylxanthones

Xanthones represent an outstanding class of oxyg~1_1ated heterocycles widespread in nature, commonly distributed in several higher plant families, such as Gentianaceae, Guttiferae and Polygalaceae and in a few families of fungi and lichens [1]. Both natural and synthetic derivatives often endowed with interesting pharmacological properties (e.g. anti-inflammatory, antitumour and antioxidant activities [1,2]. Naturally-occurring xanthones present different types .of substituents (e.g. hydroxyl, methoxyl and prenyl groups, among others) in different positions of their scaffold leading to a large variety of analogues [2]. The presence of an aryl ring attached to the xanthone core has only been reported in some synthetic derivatives [3 ,4]. We have dedicated our previous work to the development of novel methodologies for the synthesis of xanthones bearing a 2,3-diaryl substitution pattern [4]. Herein, we report the latest advances in the synthesis of novel 5-arylbenzo[ c ]xanthones 2 and 1- aryl-9H-xanthen-9-ones 4 [5]. 5-Arylbenzo[c]xanthones 2 are obtained by the Heck reaction of 3-bromoflavones 1 with styrene derivatives, leading to (E)-3-styrylflavones, followed by an one-pot photoinduced electrocyclisation and in situ oxidation of cycloadducts. The condensation of 2-methylchromone 3 with cinammaldehydes leaded to (E,E)-2-(4-arylbuta-1,3-dien-1-yl)-4H-chromen-4-ones, which after an one-pot electrocyclization and in situ oxidation of cycloadducts gave the desired 1-aryl-9Hxanthen- 9-ones 4